CN1144812C - 雄甾烯衍生物 - Google Patents

雄甾烯衍生物 Download PDF

Info

Publication number
CN1144812C
CN1144812C CNB971960755A CN97196075A CN1144812C CN 1144812 C CN1144812 C CN 1144812C CN B971960755 A CNB971960755 A CN B971960755A CN 97196075 A CN97196075 A CN 97196075A CN 1144812 C CN1144812 C CN 1144812C
Authority
CN
China
Prior art keywords
compound
dichloroacetoxy
dien
carboxylate
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB971960755A
Other languages
English (en)
Chinese (zh)
Other versions
CN1224429A (zh
Inventor
Ns
N·S·博多
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Soft Drugs Inc
Original Assignee
Soft Drugs Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21780726&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CN1144812(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Soft Drugs Inc filed Critical Soft Drugs Inc
Publication of CN1224429A publication Critical patent/CN1224429A/zh
Application granted granted Critical
Publication of CN1144812C publication Critical patent/CN1144812C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • C07J3/005—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom the carbon atom being part of a carboxylic function
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CNB971960755A 1996-05-09 1997-05-01 雄甾烯衍生物 Expired - Fee Related CN1144812C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1710296P 1996-05-09 1996-05-09
US60/017,102 1996-05-09

Publications (2)

Publication Number Publication Date
CN1224429A CN1224429A (zh) 1999-07-28
CN1144812C true CN1144812C (zh) 2004-04-07

Family

ID=21780726

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB971960755A Expired - Fee Related CN1144812C (zh) 1996-05-09 1997-05-01 雄甾烯衍生物

Country Status (19)

Country Link
US (1) US5981517A (OSRAM)
EP (1) EP0902789B1 (OSRAM)
JP (1) JP3328938B2 (OSRAM)
CN (1) CN1144812C (OSRAM)
AT (1) ATE212351T1 (OSRAM)
AU (1) AU721622B2 (OSRAM)
BR (1) BR9709062A (OSRAM)
CA (1) CA2254079C (OSRAM)
CZ (1) CZ292860B6 (OSRAM)
DE (1) DE69710065T2 (OSRAM)
DK (1) DK0902789T3 (OSRAM)
ES (1) ES2171933T3 (OSRAM)
HU (1) HUP9902449A3 (OSRAM)
NO (2) NO311646B1 (OSRAM)
NZ (1) NZ332608A (OSRAM)
PL (1) PL186637B1 (OSRAM)
PT (1) PT902789E (OSRAM)
RU (1) RU2194053C2 (OSRAM)
WO (1) WO1997042214A1 (OSRAM)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001241045A1 (en) * 2000-03-09 2001-09-17 Kissei Pharmaceutical Co. Ltd. Preventive or therapeutic drugs for eye diseases
GB0019172D0 (en) * 2000-08-05 2000-09-27 Glaxo Group Ltd Novel compounds
US6858593B2 (en) * 2000-08-05 2005-02-22 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6759398B2 (en) 2000-08-05 2004-07-06 Smithkline Beecham Corporation Anti-inflammatory androstane derivative
US6777400B2 (en) * 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6750210B2 (en) * 2000-08-05 2004-06-15 Smithkline Beecham Corporation Formulation containing novel anti-inflammatory androstane derivative
US6858596B2 (en) * 2000-08-05 2005-02-22 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivative
AU2001276497B2 (en) * 2000-08-05 2005-04-07 Glaxo Group Limited 17.beta.-carbothioate 17.alpha.-arylcarbonyloxyloxy androstane derivative as anti-inflammatory agents
US6787532B2 (en) * 2000-08-05 2004-09-07 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivatives
US6777399B2 (en) * 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
DE60113145T2 (de) 2000-11-03 2006-06-22 The University Of Manchester Selektive glucocorticoid rezeptor agonisten
UA77656C2 (en) * 2001-04-07 2007-01-15 Glaxo Group Ltd S-fluoromethyl ester of 6-alpha, 9-alpha-difluoro-17-alpha-[(2-furanylcarbonyl)oxy]-11-beta-hydroxy-16- alpha-methyl-3-oxoandrosta-1,4-dien-17-beta-carbothioacid as anti-inflammatory agent
ATE411334T1 (de) * 2001-04-30 2008-10-15 Glaxo Group Ltd Antiphlogistische 7.beta.-carbothioate esterderivate von androstan mit einer 17.alpha.- zyklischen estergruppe
ATE399174T1 (de) * 2001-06-12 2008-07-15 Glaxo Group Ltd Neue anti inflammatorische 17.alpha.- heterozyklische ester von 17.beta.-carbothioat androstan derivativen
US20050175545A1 (en) * 2002-02-04 2005-08-11 Keith Biggadike Formulation for inhalation comprising a glucocorticoid and a beta 2-adrenoreceptor agonist
GB0202635D0 (en) * 2002-02-05 2002-03-20 Glaxo Wellcome Mfg Pte Ltd Formulation containing novel anti-inflammatory androstane derivative
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
DE602004025002D1 (de) * 2003-06-19 2010-02-25 Nicholas S Bodor Steigerung der aktivität und/oder der wirkungsdauer weicher steroide mit anti-entzündungswirkung für topische oder lokale verabreichung
WO2004112800A1 (en) * 2003-06-19 2004-12-29 Bodor Nicholas S Enhancement of activity and/or duration of action of selected anti-inflammatory steroids
EP1684767A1 (en) 2003-11-03 2006-08-02 Norton Healthcare Limited Soft steroid compositions for use in dry powder inhalers
GB0507165D0 (en) * 2005-04-08 2005-05-18 Glaxo Group Ltd Novel crystalline pharmaceutical product
AR059216A1 (es) * 2006-01-27 2008-03-19 Sun Pharmaceutical Ind Ltd 11b-hidroxiandrosta-4-eno-3-onas
US7691811B2 (en) * 2006-05-25 2010-04-06 Bodor Nicholas S Transporter-enhanced corticosteroid activity and methods and compositions for treating dry eye
US7687484B2 (en) * 2006-05-25 2010-03-30 Bodor Nicholas S Transporter enhanced corticosteroid activity
GB0615108D0 (en) * 2006-07-28 2006-09-06 Glaxo Group Ltd Novel formulations
JP2020523357A (ja) * 2017-06-13 2020-08-06 ボドール ラボラトリーズ， インコーポレイテッド 強力な抗炎症ソフトコルチコステロイド化合物およびその使用
CN111100176A (zh) * 2019-12-20 2020-05-05 重庆华邦胜凯制药有限公司 一种化合物的制备方法
KR20250134584A (ko) * 2023-01-10 2025-09-11 쓰촨 케룬-바이오테크 바이오파마수티컬 컴퍼니 리미티드 글루코코르티코이드 수용체 작용제 및 이의 공액체

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE135476C (OSRAM) *
US3258473A (en) * 1963-10-04 1966-06-28 Syntex Corp 17-dihaloacetate esters of 17alpha-hydroxy-21-desoxypregnane derivatives
US3636010A (en) * 1968-12-23 1972-01-18 Ciba Geigy Corp Esters of steroid-17-carboxylic acids
GB1384372A (en) * 1971-01-20 1975-02-19 Glaxo Lab Ltd Dereivatives of 17alpha-hydroxyandrost-4-ene-17beta-carboxylic acids
US3828080A (en) * 1972-01-20 1974-08-06 Glaxo Lab Ltd Androstane-17beta-carboxylic acids and processes for the preparation thereof
GB1438940A (en) * 1972-07-19 1976-06-09 Glaxo Lab Ltd 17beta-haloalkoxycarbonyl-17alpha-oxysteroids
US4093721A (en) * 1974-08-30 1978-06-06 Glaxo Laboratories Limited Pharmaceutical compositions of 6α,9α-difluoro-androst-4-ene-17β-carboxylates and derivatives thereof
CH628355A5 (de) * 1976-02-24 1982-02-26 Ciba Geigy Ag Verfahren zur herstellung neuer androstadien-17beta-carbonsaeuren und ihrer ester und salze.
GB2014579B (en) * 1978-02-08 1982-08-25 Glaxo Group Ltd Chloromethyl 17 acetoxy fluoro hydroxy 16 methyl 3 oxoandrosta 1,4 diene 17 carboxylate
US4188385A (en) * 1978-04-05 1980-02-12 Syntex (U.S.A.) Inc. Thioetianic acid derivatives
US4263289A (en) * 1978-04-05 1981-04-21 Syntex (U.S.A.) Inc. Thio etianic acid derivatives
US4198403A (en) * 1978-04-05 1980-04-15 Syntex (U.S.A.) Inc. 17 Beta-thiocarboxylic acid esters of 4-halo-3-oxoandrost-4-enes
ZA81976B (en) * 1980-02-15 1982-07-28 Glaxo Group Ltd Androstane carbothioates
US4578221A (en) * 1980-04-23 1986-03-25 Glaxo Group Limited Androstane carbothioic acids
US4710495A (en) * 1980-07-10 1987-12-01 Otsuka Pharmaceutical Co., Ltd. Soft steroids having anti-inflammatory activity
US4996335A (en) * 1980-07-10 1991-02-26 Nicholas S. Bodor Soft steroids having anti-inflammatory activity
US4607028A (en) * 1983-08-18 1986-08-19 Ciba-Geigy Corporation Novel carboxylic acid esters
FR2551069B1 (fr) * 1983-08-26 1986-07-25 Jouveinal Sa 17-oxo-21-thioesters d'hydrocortisone, leur preparation et leurs applications comme medicament
JPS617291A (ja) * 1984-06-20 1986-01-13 Mitsubishi Chem Ind Ltd 新規なコルチコイド誘導体およびその製法
PT78973A (en) * 1984-07-25 1984-08-01 Joao Emerico Villax New preparation process of the 9alpha-fluoro 17,21-acylates or hidroxilades in 17 and 21 chloro-corticosteroid
US5223493A (en) * 1984-12-28 1993-06-29 Alcon Laboratories, Inc. Anti-inflammatory compounds for ophthalmic use
US5026639A (en) * 1988-01-14 1991-06-25 Nippon Mining Company, Limited Method to improve mRNA translation and use thereof for production of platelet factor-4
DE4025342A1 (de) * 1990-08-10 1992-02-13 Hoechst Ag In 17-stellung substituierte corticoid-17-alkylcarbonate, verfahren zu deren herstellung und diese enthaltende arzneimittel

Also Published As

Publication number Publication date
CZ292860B6 (cs) 2003-12-17
EP0902789B1 (en) 2002-01-23
EP0902789A1 (en) 1999-03-24
NO985232D0 (no) 1998-11-09
DK0902789T3 (da) 2002-05-06
ATE212351T1 (de) 2002-02-15
AU721622B2 (en) 2000-07-13
WO1997042214A1 (en) 1997-11-13
CN1224429A (zh) 1999-07-28
CA2254079C (en) 2004-09-14
NZ332608A (en) 2000-01-28
PT902789E (pt) 2002-07-31
RU2194053C2 (ru) 2002-12-10
AU2740797A (en) 1997-11-26
HUP9902449A2 (hu) 1999-11-29
PL186637B1 (pl) 2004-02-27
BR9709062A (pt) 2000-01-04
HUP9902449A3 (en) 2000-03-28
DE69710065D1 (de) 2002-03-14
NO311646B1 (no) 2001-12-27
ES2171933T3 (es) 2002-09-16
JP2000509716A (ja) 2000-08-02
CZ361698A3 (cs) 1999-03-17
JP3328938B2 (ja) 2002-09-30
NO20015790D0 (no) 2001-11-27
HK1021539A1 (en) 2000-06-16
NO985232L (no) 1998-12-04
US5981517A (en) 1999-11-09
DE69710065T2 (de) 2002-08-29
CA2254079A1 (en) 1997-11-13
NO315425B1 (no) 2003-09-01
PL329802A1 (en) 1999-04-12
EP0902789A4 (OSRAM) 1999-04-14
NO20015790L (no) 1998-05-04

Similar Documents

Publication Publication Date Title
CN1144812C (zh) 雄甾烯衍生物
CN1294142C (zh) 作为抗炎剂的17β－硫代羧酸酯17α－芳基羰氧基雄甾烷衍生物
CN1171883C (zh) 非甾体抗炎药
CN1036342C (zh) 9，11-脱氢甾类化合物及9-α-羟基-16，17-脱氢甾类化合物的制备方法
CN1026236C (zh) 甾类5-α-还原酶抑制剂的制备方法
CN1158297C (zh) 用于治疗的具有c-17烷基侧链和芳香a-环的甾族化合物
CN1064078A (zh) 新的甾酯类
CN1163492C (zh) △12,13－异紫杉酚类似物、其抗肿瘤的用途和含有这些化合物的药物组合物
CN1269836C (zh) 用于改进抗炎治疗的细胞靶向的免疫细胞特异性大环内酯化合物与抗炎化合物的共轭物
CN1296380C (zh) 药用化合物
CN1085899A (zh) 7(2-氨乙基)-苯并噻唑酮
CN1165337C (zh) 新的合成隐藻菌素
CN1037773C (zh) 含杂原子的三环化合物
CN1777619A (zh) 具有抗炎活性的大环内酯类配合物
CN1140527C (zh) 苯基黄嘌呤酯和酰胺衍生物
CN1068816A (zh) 吲哚类衍生物
CN1079465A (zh) 吲哚类
CN1751059A (zh) 具有抗肿瘤活性的2－取代的雌－1,3,5(10)－三烯－3－基氨基磺酸酯
CN1157404C (zh) 新的梭链孢酸衍生物
CN1102529A (zh) 氟化4-氨基雄甾二烯酮衍生物及其制备方法
CN1196720A (zh) 新的维生素d类似物
HK1021539B (en) Androstene derivatives
CN1052003C (zh) 3－酰基－2－羟吲哚－1－甲酰胺类抗炎前药
CN1993375A (zh) 具有雄激素作用的甾类前药
CN1816560A (zh) 新的夫西地酸衍生物

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
REG Reference to a national code

Ref country code: HK

Ref legal event code: GR

Ref document number: 1021539

Country of ref document: HK

C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20040407